Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omkar Speciality Chemicals is an India-based public manufacturer of specialty chemicals and pharmaceutical intermediates. The company produces organic, inorganic, and organo-inorganic intermediates, with product families centered on iodine, selenium, molybdenum, cobalt, bismuth, tungsten, and tartaric-acid derivatives. Its end markets include pharmaceuticals as the largest segment, along with poultry, glass, and water-treatment applications. Omkar is not a drug developer and does not appear to run a therapeutic pipeline; rather, it operates as a commercial chemicals supplier serving industrial and pharma-related customers. The company is listed on the BSE and NSE in India and has manufacturing operations in Badlapur, Maharashtra.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omkar Speciality Chemicals.